Kringle Pharma,Inc. (4884) Dividends
Market cap
¥2.7B
P/E ratio
-2.3x
Kringel Pharma develops treatments for rare diseases like spinal cord injury and ALS using recombinant human HGF protein technology for medical institutions and pharma partners.
Latest Dividend per Share Forecast
0.00JPY
If you buy 100 shares of Kringle Pharma,Inc., the expected annual dividend is 0 JPY.
- Dividend Yield
- -
- Payout Ratio
- -
Dividend Policy
<p>The company determines dividends while considering the need to build up retained earnings for research and development investment. For the time being, no dividend is planned. When the company consistently achieves sufficient profits in the future, it will consider paying dividends. If dividends are implemented, the basic policy will be to pay dividends once a year at the fiscal year-end.</p>
Dividend per Share
Payout Ratio
Dividend Yield
Dividend History (Forecasts, Revisions, Actuals)
| Fiscal Year | Type | Interim | Year-End | Total | Payout Ratio |
| FY2026 | Forecast(2025/11/12) | 0 | 0 | 0 | - |
|---|---|---|---|---|---|
| FY2025 | Actual(2025/11/12) | 0 | 0 | 0 | - |
| Forecast(2024/11/13) | 0 | 0 | 0 | - | |
| FY2024 | Actual(2024/11/13) | 0 | 0 | 0 | - |
| Forecast(2023/11/13) | 0 | 0 | 0 | - | |
| FY2023 | Actual(2023/11/13) | 0 | 0 | 0 | - |
| Forecast(2022/11/14) | 0 | 0 | 0 | - | |
| FY2022 | Actual(2022/11/14) | 0 | 0 | 0 | - |
| Forecast(2021/11/12) | 0 | 0 | 0 | - | |
| FY2021 | Actual(2021/11/12) | 0 | 0 | 0 | - |
| Revision(2021/08/13) | - | 0 | 0 | - | |
| Forecast(2021/02/12) | 0 | 0 | 0 | - | |
| FY2020 | Actual(2021/02/12) | - | 0 | 0 | - |